Latest in Ingredients

DFE Pharma achieves ISO 22301 certification for BCMS

DFE Pharma's Business Continuity Management System (BCMS) at its head office in Goch, Germany helps it to effectively maintain its operations

Find out more

Persist AI debuts Cloud Lab platform for faster pharmaceutical formulation development

The AI-powered robotic technology helps pharmaceutical companies test and develop formulations quickly and effectively
See more

Roquette debuts Health & Pharma Solutions, Nutrition & Bioindustry subsidiaries

The company has created two new organisations; Roquette Health & Pharma and Roquette Nutrition & Bioindustry, following its acquisition of IFF Pharma Solutions
You need to be a subscriber to read this article.
Click here to find out more.

Strengthening drug substance development with robust RSM strategies

Qixuan Lu, Vice President of Process Chemistry at BioDuro, explains why regulatory starting materials represent the foundation of pharmaceutical manufacturing

Servier inaugurates €150m API production unit at Normandy site

The new production unit will be responsible for the manufacture of an active ingredient used to treat venous diseases
You need to be a subscriber to read this article.
Click here to find out more.

PROTACs: current landscape and their significance in drug discovery

PROteolysis TArgeting Chimeras (PROTACs) represent a revolutionary approach to drug discovery that leverages their chemically induced proximity to degrade disease-causing proteins using the cellular ubiquitin-proteasome system

dsm-firmenich launches pharmaceutical taste solutions portfolio

The range aims to improve the taste and sensory experience of solid, liquid or semi-solid dosage forms

ABVC BioPharma to invest $220m into US pharmaceutical manufacturing, raw material cultivation

Following its recent $100m pharma manufacturing investment, ABVC plans to integrate its production capacity with new botanical raw material cultivation capacity in the US

dsm-firmenich's CBtru demonstrates similar bioavailability to commercially available Epidiolex

The cannabidiol (CBD)-based drug product intermediate is absorbed into the bloodstream at a similar level compared with the only commercially approved CBD drug, Epidiolex

Optimising early-stage drug development with continuous processing

Pharmaceutical innovators face many challenges when developing new products; as such, getting them to market in a timely, safe and cost-effective way is critical. The use of continuous manufacturing technologies can help to overcome some of the most pressing early-stage obstacles

Latest posts in Ingredients

Indena becomes first API manufacturer to receive European CEP certification

Its CBD extract is the first to receive the European Pharmacopoeia Certificate of Eligibility from the European Directorate for the Quality of Medicines (EDQM)
You need to be a subscriber to read this article.
Click here to find out more.

Beginnings, endings and transitions: Janus and the business of pharmaceuticals

Dr Kevin Robinson recently caught up with pharmaceutical industry experts to review what they considered to be the sector’s key challenges and achievements in 2024 and what trends, technologies or regulatory shifts they anticipate will shape the industry in 2025

Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription

With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence

Europa Biosite acquires life science product and service supplier, AMSBIO

Europa Biosite will now be able to expand its presence across the key US market, while also bolstering its offerings in stem cell research, regenerative medicine and biospecimens

Ingenza and HydRegen collaborate to optimise biomanufacturing sustainability

The companies will work together to optimise and scale HydRegen's range of amine-based biocatalysts, which are more sustainable and cost-effective than traditional metal catalysts

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies

Rousselot and IamFluidics launch dissolvable microcarrier for cell culturing

The alginate and denatured collagen based product allows researchers to produce scalable cell cultures for biologic drugs and cell therapies

Logical Biological expands its raw pharma material development and supply capabilities with new lab

The raw material supplier can now better serve in vitro diagnostic (IVD) manufacturers, as it has a significantly larger operational capacity

Biosynth inaugurates its Biological Technology site in Suzhou, China

The new site will serve the Chinese domestic market, providing raw materials for vaccines and pharmaceuticals, while dealing regional distribution and handling

Seppic launches surfactant excipient for the optimisation of biological formulations

The ingredient is compatible with sensitive biologics, and aims to stabilise injectables for improved bioavailability, efficacy and shelf life

Beneo presents its taste-boosting excipient, galenIQ at CPHI 2024

galenIQ is designed to improve the flavour of oral solid dosage (OSD) forms for more patient-centric pharmaceuticals

Indena showcases its CDMO services and HPAPI capabilities at CPHI 2024

The company will display its range of high-potency APIs, as well as its ADC and linker payload development and manufacturing capabilities

Sponsor content

Ensuring API compatibility for successful formulation development

In the pharmaceutical industry, the successful development of a new drug product hinges on the compatibility between the active pharmaceutical ingredient (API) and its...

IFF Pharma Solutions brings next-gen excipient innovations to CPHI Japan 2025

Global leading excipient supplier to highlight innovations in oral disintegrating tablets, controlled release formulations, and low-nitrite solutions

C2 PHARMA receives CEP approval for Oxybuprocaine hydrochloride

C2 PHARMA proudly announces the approval of a Certificate of Suitability (CEP) for Oxybuprocaine hydrochloride by the European Directorate for the Quality of Medicines and...

Gelita launches Endotoxin Controlled Excipients for bioscience applications

New portfolio comprises innovative collagen solutions for parenteral applications, medical devices and 3D bioprinting

Therapeutic: felzartamab for kidney disease

Immunoglobulin A nephropathy (IgAN) or Berger disease is the most common form of primary glomerulonephritis and a leading cause of chronic kidney disease

Therapeutic: vimseltinib for tenosynovial giant cell tumour

Tenosynovial giant cell tumour (TGCT) is a rare, non-malignant tumour that results from a translocation in the colony stimulating factor 1 (CSF1) gene

Therapeutic: brensocatib for bronchiectasis

The chronic lung disease bronchiectasis is a serious condition in which the bronchi become permanently dilated because of a cycle of infection, inflammation and damage to...

New small-scale In-Line mixer range from Silverson Machines

Silverson launches versatile small-scale mixers for pharma and biotech applications

Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx

The acquisition strengthens Actylis’ presence in the VMS and OTC markets

Therapeutic: anticancer agent ivonescimab

The advent of PD-1 and PD-L1 targeting antibodies has transformed the outlook for many cancer patients by harnessing the body’s immune system to fight tumour cells

Therapeutic: seladelpar for primary biliary cholangitis

The chronic and progressive autoimmune liver disease, primary biliary cholangitis, affects the bile ducts running through the liver and slowly degrades them

C2 PHARMA marks 10 years at CPHI Milan with expanded ophthalmic APIs

The complany is ready to showcase its expanding ophthalmic API portfolio and global regulatory filings, featuring Naphazoline Hydrochloride and Tropicamide

Featured companies

Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or... At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Our community of around 17,500 skilled employees work across a... Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life... We are a global leader in the development and manufacturing of active pharmaceutical ingredients, focused on specialist niches with expertise in highly regulated and complex...
See more